Cooley advised Cholesgen on the deal. Cholesgen (Shanghai) Co.Ltd. announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with...
Cholesgen’s Research Collaboration and Licensing Agreement with AstraZeneca
United State of America v. Lazaro Hernandez
Patterson Belknap Webb & Tyler represented Gilead in the case. A Florida federal judge sentenced Lazaro Hernandez to 15 years for allegedly distributing over $230 million...
Kentucky Power Company’s $65 Million Tax-Exempt Bond Remarketing
Hunton Andrews Kurth LLP acted as counsel to the remarketing agent in the deal. Kentucky Power Company announced the remarketing of $65 million aggregate principal amount of...
RadNet’s $259.2 Million Common Stock Public Offering
Sheppard Mullin represented RadNet, and Latham & Watkins represented the underwriters. RadNet, Inc. (NASDAQ: RDNT) has announced the closing of its underwritten public offering of 8,711,250 shares...
Hopewell Therapeutics’ $25 Million Seed Financing
Mintz advised Hopewell Therapeutics in the transaction. Hopewell Therapeutics, a biotechnology company with a differentiated lipid nanoparticle platform harnessing unique ionizable lipid chemistry, in its Seed...
Aeglea’s Acquisition of Spyre
Gibson, Dunn & Crutcher LLP is advising Spyre Therapeutics, Inc. in the transaction, while Cooley LLPis advising Aeglea. Aeglea BioTherapeutics, Inc. (“Aeglea”) (NASDAQ: AGLE), announced it has completed...
Verne Global’s $100 Million Green Loan Financing
Taylor Wessing advised Verne Global, and Latham & Watkins advised Natixis. Verne Global announced a $100 million senior secured green term loan financing to repay a bridge facility, and...